NUTRIBAND INC COM NEW (NTRB)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CEO:
Gareth R. Sheridan
Employees:
10
309 CELTIC COURT, OVIEDO, FL 32765
385-881-3385

Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl system.

Data derived from most recent annual or quarterly report
Market Cap 19.113 Million Shares Outstanding7.833 Million Avg 30-day Volume 8.756 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.14
Price to Revenue13.7483 Debt to Equity0.014 EBITDA-4.115 Million
Price to Book Value3.335 Operating Margin-215.1936 Enterprise Value26.726 Million
Current Ratio3.598 EPS Growth0 Quick Ratio2.803
1 Yr BETA 0.6192 52-week High/Low 6.98 / 2.41 Profit Margin-215.5922
Operating Cash Flow Growth-6.3354 Altman Z-Score14.991 Free Cash Flow to Firm -2.758 Million
View SEC Filings from NTRB instead.

View recent insider trading info

NUTRIBAND INC COM NEW YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding NTRB (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding NTRB

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-03-08 by MELNIK SERGUEI
  • 5/A: filed on 2022-10-25 by MELNIK SERGUEI
  • 5/A: filed on 2022-10-25 by SHERIDAN GARETH
  • 4: filed on 2022-07-07 by SHERIDAN GARETH
  • 5: filed on 2022-07-05 by MELNIK SERGUEI
  • 5: filed on 2022-07-05 by SHERIDAN GARETH
  • 5: filed on 2022-07-05 by SHERIDAN GARETH
  • 4/A: filed on 2022-02-25 by MELNIK SERGUEI
  • 4/A: filed on 2022-02-24 by MELNIK SERGUEI
  • 4: filed on 2022-02-24 by MELNIK SERGUEI

    • Events (8k)

  • 8-K: filed on 2023-03-29:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-05:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-12-30:
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-10-06:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-19:
    Item 3.02: Unregistered Sales of Equity Securities
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-08-10:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-01:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-27:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-26:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-15:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    MELNIK SERGUEI CHAIRMAN AND PRESIDENT

    • Officer
    • Director
    • 10% Owner
    		 827,999 2023-03-06 1

    SHERIDAN GARETH CEO

    • Officer
    • Director
    • 10% Owner
    		 1,510,000 2022-05-10 0

    DAVIDOV MICHAEL

    • Director
    		 5,000 2018-07-31 0

    BOTGROS VITALIE CHAIRMAN OF THE BOD

    • Officer
    • Director
    • 10% Owner
    		 3,000,000 2017-01-31 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    NUTRIBAND INC NTRB 2023-05-31 22:15:04 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 21:45:04 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 21:15:03 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 20:45:04 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 20:15:06 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 19:45:04 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 19:15:21 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 18:45:03 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 18:15:04 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 17:45:03 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 17:15:05 UTC -126.4171 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 16:45:04 UTC -126.4071 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 16:15:04 UTC -126.4071 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 15:45:03 UTC -126.4071 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 15:15:04 UTC -126.4071 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 14:45:04 UTC -126.4071 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 14:15:03 UTC -126.4071 131.4771 55000
    NUTRIBAND INC NTRB 2023-05-31 13:45:04 UTC -126.3157 131.3857 55000
    NUTRIBAND INC NTRB 2023-05-31 13:15:04 UTC -126.3157 131.3857 55000
    NUTRIBAND INC NTRB 2023-05-31 12:45:04 UTC -126.3157 131.3857 55000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments